Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Geovax, Inc.

Clinical trials sponsored by Geovax, Inc., explained in plain language.

GeoVax, Inc. GOVX NASDAQ

A clinical-stage biotech developing vaccines and immunotherapies for infectious diseases and cancer.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1 Completed 1

New COVID-19 vaccine shows promise in early trial

⭐️ VACCINE ⭐️ Completed

This study tested a new COVID-19 vaccine called GEO-CM04S1 in 119 healthy adults. The vaccine uses a modified virus to teach the body to fight SARS-CoV-2. Researchers checked for side effects and measured antibody levels to see if the vaccine works. The trial is now complete.

Phase: PHASE1, PHASE2 • Sponsor: GeoVax, Inc. • Aim: ⭐️ VACCINE ⭐️

Last updated Jun 27, 2026 09:03 UTC